article

Mass Spectrometry In-Depth Focus 2012

In this free to view Mass Spectrometry In-Depth Focus: Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics; Quantification of membrane drug transporters and application in drug discovery and development; Mass spectrometry leaders roundtable…

Mass Spectrometry supplement 2012
  • Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics
    Ana Rita Angelino and Min Yang, Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy
  • Quantification of membrane drug transporters and application in drug discovery and development
    Tasso Miliotis and Constanze Hilgendorf, Innovative Medicines, AstraZeneca R&D
  • Show preview – The 60th annual conference on Mass Spectrometry and Allied Topics
  • Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
    George McLeod, Market Manager, Pharmaceutical MS, Bruker Daltonics / Detlev Hochmuth, Scientific Consultant and Software Developer for MS and Chemoinformatics, Dr. Hochmuth Scientific Consulting / Alessandro Baldi, VP & General Manager, Protea Biosciences Inc / Gary Harland, Mass Spectrometry Product Manager, Waters Corporation

This Mass Spectrometry In-Depth Focus is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend